A trial to compare the effectiveness of two different dose of a drug bupivacaine (0.125% and0.25%) in US guided PENG block ease of positioning for regional anaesthesia( spinal )for hip surgery patients
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/064128
- Lead Sponsor
- Dr RPGMC Kangra Tanda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient scheduled for hip surgeries under subarachnoid block who are American Society of Anaesthesiologist (ASA) physical status I -III and consenting
Exclusion Criteria
1.Fractures older than 2 weeks
2.Patients who were unwilling
3.Patients having no pain while sitting
4.Any bleeding disorder and patient on anticoagulants
5.Neurological and musculoskeletal disease
6.Local infection at the injection site
7.History of allergy to local anaesthetic and signs of allergy to lignocaine test dose
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compare ease of positioning for spinal anaesthesia with 0.125% and 0.25% bupivacaine in US guided PENG block within 30 min of administrationTimepoint: 30 minutes after Us guided PENG block
- Secondary Outcome Measures
Name Time Method Haemodynamic monitors at rest and 15 degrees leg elevation at 0,10 and 20,30 minutes after giving US guided PENG blockTimepoint: 3yrs;Time to rescue analgesia in the two groups will be notedTimepoint: 3yrs;To analyse pain using visual analogue scale at rest and 15 degrees passive leg elevation at 0,10 and 20,30 minutes after giving US guided PENG blockTimepoint: 3yrs